OrthoPediatrics Corp.

Equities

KIDS

US68752L1008

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 04:00:00 2024-04-18 pm EDT 5-day change 1st Jan Change
29.46 USD -1.47% Intraday chart for OrthoPediatrics Corp. -6.65% -9.38%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Truist Securities Adjusts Price Target on OrthoPediatrics to $32 From $31, Maintains Hold Rating MT
Transcript : OrthoPediatrics Corp., Q4 2023 Earnings Call, Mar 07, 2024
OrthoPediatrics Corp. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 CI
Earnings Flash (KIDS) ORTHOPEDIATRICS Reports Q4 Revenue $37.6M, vs. Street Est of $37.7M MT
Orthopediatrics Corp. Reiterates Revenue Guidance for Full Year 2024 CI
North American Morning Briefing : Stock Futures -2- DJ
OrthoPediatrics Corp. Launches New RESPONSE Rib and Pelvic Fixation System for EOS Scoliosis CI
North American Morning Briefing : Intel Drags Down -2- DJ
OrthoPediatrics Shares Fall After Truist Securities Downgrade MT
Truist Securities Downgrades OrthoPediatrics to Hold From Buy, Adjusts Price Target to $31 From $39 MT
OrthoPediatrics Corp. Provides Preliminary Unaudited Revenue Guidance Fourth Quarter and Full Year 2023 and for the Year 2024 CI
OrthoPediatrics Corp. acquired Boston Orthotics & Prosthetics for $24.5 million. CI
Orthopediatrics Corp. Enters into Credit, Security and Guaranty Agreement CI
Truist Securities Adjusts Price Target on OrthoPediatrics to $39 From $35, Maintains Buy Rating MT
OrthoPediatrics Introduces Specialty Bracing Division MT
OrthoPediatrics Corp. Announces Launch of Specialty Bracing Division CI
Truist Adjusts Price Target on OrthoPediatrics to $35 From $31, Maintains Buy Rating MT
Needham Cuts OrthoPediatrics' Price Target to $37 From $55, Maintains Buy Rating MT
Transcript : OrthoPediatrics Corp., Q3 2023 Earnings Call, Nov 07, 2023
Earnings Flash (KIDS) ORTHOPEDIATRICS Posts Q3 Revenue $40M, vs. Street Est of $40.4M MT
OrthoPediatrics Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
OrthoPediatrics Corp. Reiterates Earnings Guidance for the Full Year of 2023 CI
OrthoPediatrics Gets Distribution Contract with Ora Medical MT
OrthoPediatrics Corp. Enters Distribution Agreement with Ora Medical CI
OrthoPediatrics Corp. acquired Assets of Rhino Pediatric Orthopedic Designs, Inc. for $0.85 million. CI
Chart OrthoPediatrics Corp.
More charts
OrthoPediatrics Corp. is an orthopedic company, which is focused on advancing the field of pediatric orthopedics. The Company is engaged in designing, developing, and marketing anatomically appropriate implants and devices for children with orthopedic conditions, giving pediatric orthopedic surgeons and caregivers. The Company sells its specialized products, including PediLoc, PediPlates, Cannulated Screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIRO Growth Modulation System, PNP Tibia System, ApiFix Mid-C System and Mitchell Ponset specialized bracing products to various hospitals and medical facilities throughout the United States and various international markets. It markets 53 surgical and specialized bracing systems.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
29.46 USD
Average target price
40 USD
Spread / Average Target
+35.78%
Consensus
  1. Stock Market
  2. Equities
  3. KIDS Stock
  4. News OrthoPediatrics Corp.
  5. BTIG Adjusts OrthoPediatrics' Price Target to $61 from $65, Keeps Buy Rating